LifeStance Health Group (NASDAQ:LFST) and New York Health Care (OTCMKTS:BBAL) Critical Analysis

LifeStance Health Group (NASDAQ:LFST) and New York Health Care (OTCMKTS:BBAL) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, dividends, analyst recommendations, valuation and earnings.

Analyst Ratings

This is a breakdown of current recommendations and price targets for LifeStance Health Group and New York Health Care, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeStance Health Group	0	3	6	2	2.91
New York Health Care	0	0	0	0	0.00

LifeStance Health Group currently has a consensus target price of $9.75, indicating a potential upside of 14.71%. Given LifeStance Health Group’s stronger consensus rating and higher probable upside, research analysts plainly believe LifeStance Health Group is more favorable than New York Health Care.

Institutional and Insider Ownership

85.5% of LifeStance Health Group shares are held by institutional investors. 3.2% of LifeStance Health Group shares are held by company insiders. Comparatively, 6.7% of New York Health Care shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Risk and Volatility

LifeStance Health Group has a beta of 1.19, meaning that its share price is 19% more volatile than the S&P 500. Comparatively, New York Health Care has a beta of 0.56, meaning that its share price is 44% less volatile than the S&P 500.

Profitability

This table compares LifeStance Health Group and New York Health Care’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
LifeStance Health Group	1.55%	1.56%	1.07%
New York Health Care	N/A	N/A	N/A

Earnings & Valuation

This table compares LifeStance Health Group and New York Health Care”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeStance Health Group	$1.42 billion	2.31	$9.66 million	$0.06	141.67
New York Health Care	N/A	N/A	N/A	N/A	N/A

LifeStance Health Group has higher revenue and earnings than New York Health Care.

Summary

LifeStance Health Group beats New York Health Care on 10 of the 11 factors compared between the two stocks.

About LifeStance Health Group

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

About New York Health Care

New York Health Care, Inc. operates as a home care services agency primarily in New York. The company offers various home care services, such as companionship services, homemaker/housekeeper staff, professional and practical nurses, home health aides, care givers, geriatric care, and dementia and alzheimer care services. It also provides insurance services. The company was founded in 1983 and is based in Valley Stream, New York.